180 related articles for article (PubMed ID: 29320755)
1. Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer.
Zhou N; Liu C; Wang X; Mao Q; Jin Q; Li P
Hum Pathol; 2018 Apr; 74():83-91. PubMed ID: 29320755
[TBL] [Abstract][Full Text] [Related]
2. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer.
Hur H; Kim YB; Ham IH; Lee D
J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
4. High SLC17A9 expression correlates with poor survival in gastric carcinoma.
Li J; Su T; Yang L; Deng L; Zhang C; He Y
Future Oncol; 2019 Dec; 15(36):4155-4166. PubMed ID: 31799885
[No Abstract] [Full Text] [Related]
5. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
Li C; Ji L; Ding ZY; Zhang QD; Huang GR
Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.
Rimkus C; Martini M; Friederichs J; Rosenberg R; Doll D; Siewert JR; Holzmann B; Janssen KP
Br J Cancer; 2006 Nov; 95(10):1419-23. PubMed ID: 17088907
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
11. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
[TBL] [Abstract][Full Text] [Related]
14. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
15. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
[TBL] [Abstract][Full Text] [Related]
16. Expression and significance of intratumoral interleukin-12 and interleukin-18 in human gastric carcinoma.
Ye ZB; Ma T; Li H; Jin XL; Xu HM
World J Gastroenterol; 2007 Mar; 13(11):1747-51. PubMed ID: 17461482
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
19. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
20. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
